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Abstract
Background: Diastolic heart failure is a common and deadly complication of diabetes mellitus, with the development
of diabetic cardiomyopathy as one of the key determinants of the disease’s complex pathology. The cause of the
association is unknown and has no approved therapy strategies as of yet. However significant advances in this area
may come from studies on suitable animal models.
Methods: A total of 25 male rhesus monkeys (12-16 years, 9-13 kg) were enrolled. Fifteen of them were diagnosed as
spontaneous type 2 diabetes mellitus (T2DM, FPG ≥ 104 mg/dl, HbA1c: 4.7-5.5 %, diabetes duration: 1-4 years).
The other 10 monkeys were non-diabetic (ND, FPG < 90 mg/dl). Echocardiography and cardiac magnetic resonance
were used for evaluating the cardiac structure and function. One T2DM monkey with impaired diastolic function and
another ND monkey were both sacrificed to gain the necessary pathology and protein expression studies
displayed here.
Results: Six out of 15 T2DM rhesus monkeys were diagnosed with diastolic dysfunction (DD) by echocardiography.
Additionally, no abnormalities were found in the group which we determined as the ND monkeys. The six DD
monkeys all showed low e’ velocity and decreased e’/a’ ratio, among which three of them showing decreased
E/A ratio and the other 3 having elevated E/A ratio, this appears to be similar to the impaired relaxation pattern and
pseudonormal pattern found in human patients respectively. The EF and FS of monkeys with pseudonormal pattern
decreased significantly compared with ND subjects. A CMR study showed that LVID at end systole of 5 DD monkeys is
significantly longer than that of 3 ND monkeys. Of great interest, myocardium lesions and mitochondria impairments
and increased expression of AGEs and caspase-3 were found in a sacrificed DD subject.
Conclusion: The changes in the imaging and physiological markers of spontaneous T2DM rhesus monkeys are
similar to those key markers found in human type 2 diabetes and diastolic dysfunction. This monkey model
could help the medical community and us to understand the pathology of this debilitating disease and serve
as a beginning to explore important measures to prevent and treat diabetic cardiomyopathy.
* Correspondence: gaofabao@yahoo.com; zengwen10@vip.163.com
3Department of Radiology, West China Hospital, Sichuan University,
Chengdu, China
1Sichuan Industrial Institute of Antibiotics, Chengdu, China
Full list of author information is available at the end of the article
© 2015 Qian et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium,
provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Qian et al. BMC Cardiovascular Disorders  (2015) 15:59 
DOI 10.1186/s12872-015-0046-9
Background
Cardiovascular diseases (CVD) are the leading causes of
death and disability among people with diabetes. At
least 65 % of people with diabetes die from certain
forms of cardiovascular diseases [1]. As a major out-
come of diabetes, cardiac failure is the most severe
comorbidity [2]. A high prevalence of cardiac failure is
seen in individuals with diabetic cardiovascular compli-
cations, therefore diabetic cardiomyopathy (DCM) is
one of the key determinants in understanding and con-
trolling the dire effects of the onset and progression of
diabetes mellitus [3].
DCM has been defined as ventricular dysfunction
that occurs in diabetic patients independent of a recog-
nized cause, such as coronary artery disease (CAD) or
hypertension [4]. Additionally, DCM is marked by
diastolic dysfunction (DD) early on the disease’s
progression [5–7] that leads to the loss of contractile
(systolic) function as time passes by [7–9]. The patho-
genesis of this ventricular dysfunction remains unknown,
but several hypotheses have been proposed, including
autonomic dysfunction, metabolic derangements, abnor-
malities in ion homeostasis, alteration in structural
proteins and the presence of interstitial fibrosis.
Alterations of certain biomarkers have also been
reported to play key roles in the development of cardiac
dysfunction and are therefore important to monitor. For
example, advanced glycosylation end products (AGEs)
can covalently crosslink and biochemically modify colla-
gen structures in diabetes induced myocardial stiffness
[10]. Another biomarker of interest is caspase-3 activa-
tion triggered by ROS generation in hyperglycemia-
induced cardiac cell apoptosis in vivo [11]. Monitoring
PKA-mediated phosphorylation of cMyBP-C is also
helpful as it is linked to the modulation of cardiac
contractions [12]. Determinations of these biomarkers
contribute to providing the evidence of impairments
by monitoring the abnormal effects in different meta-
bolic pathways.
Significant advances in diabetic-related diseases may
come from the studies on suitable animal models.
Abnormalities in cardiac functionality and structure in
diabetic subjects have been demonstrated in a variety of
type 1 and type 2 diabetic rodent models [13–18]. In
most studies of type 1 diabetes mellitus, diabetes is
induced after administration of the pancreatic beta-cell
toxin streptozotocin (STZ). Additionally, most studies of
type 2 diabetes mellitus have been performed in genetic
models demonstrating obesity and insulin resistance
such as the Zucker fatty rat or db/db mice, both of
which have mutations that impair leptin receptor
signaling, or ob/ob mice, which lack leptin [4]. STZ
induced and transgenic/gene knock-out diabetic rodent
models may have advantages in studying some
particular mechanisms. However, as for the compli-
cated pathogenesis of DM, neither the rats nor the mice
appear to have similar cardiac dysfunction that stimu-
lates diabetic cardiomyopathy in diabetic humans.
Compared with other animal models, rhesus monkeys
(Macaca mulatta) are more similar to humans in physi-
ology and to the susceptibility of known metabolic
diseases in human patients [19]. Though naturally occur-
ring spontaneous type 2 diabetes has been extensively
studied in rhesus [20–22], diabetic cardiovascular com-
plications in rhesus monkeys have not been adequately
discerned. In our previous work, a certain number of
spontaneous T2DM rhesus monkeys have been screened
and found within our colony, and their DM related
parameters were demonstrated to be similar to humans
[23]. Therefore, to investigate cardiac characteristics of
those subjects, T2DM and age matched non-diabetic
(ND) rhesus monkeys were enrolled in this study.
Multiple complementary image techniques such as M-
mode echocardiography, pulsed wave Doppler ultra-
sound, tissue Doppler imaging and cardiac magnetic
resonance (CMR) were used to assess and categorize
the DD group. Furthermore, light-scope was utilized to
observe the microstructure within major organs to help
us visualize the pathology present. Transmission elec-
tron microscope (TEM) was also used to observe the
myocardium mitochondrial ultrastructure. These images
were obtained through the application of immunohisto-




Fifteen previously screened spontaneous T2DM rhesus
monkeys from ages 12 to 16 years, with 1–4 years’
duration of diabetes [23] were matched with 10 ND rhe-
sus monkeys of a similar age for testing. The criteria
used for the rhesus monkey selections were guided by
our previous work [23] along with similar criteria for
rhesus monkeys [24, 25]. Monkeys were singly housed in
a climate controlled room at 19 °C to 26 °C (66 °F to
79 °F), with a relative humidity of 50 % ± 20 %. The rate
of ventilation was 10 times/h and the lighting cycle was
12 (day)/12 (night) hours. Monkeys were continually fed
with mild high-calorie diet (containing 18 % protein,
60 % carbohydrates, 14 % water, and 8 % fat) approxi-
mately 300 g/day; a daily allotment of apples or vege-
table was also provided. Tap water was provided as
drinking water ad libitum. The monkeys were main-
tained in conformity with the requirements of “the
National Institutes of Health Guide for the Care and Use
of Laboratory Animal” of the United States, and all
experimental protocols had been reviewed and approved
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by the Institutional Animal Care and Use Committee of
Sichuan PriMed Group Co., Ltd.
Trial arrangements
There was a 4-week long acclimation period before the
initial image study, during which gravimetry and meta-
bolic profiles of all enrolled monkeys were acquired, see
Table 1. Fasting plasma glucose (FPG) were determined
semi-monthly for four weeks. Hemoglobin A1c (HbA1c),
2 h post-challenge plasma glucose (2hPPG), total
cholesterol (TC), triglyceride (TG), low density lipopro-
tein cholesterol (LDL-c) and high density lipoprotein
cholesterol (HDL-c) were determined at the end of the
acclimation period. Body weight (BW), crown-rump
length (CRL) of all monkeys were measured after the last
blood collection to calculate BMI. Blood pressure of all
the monkeys were measured before each image examin-
ation. Echocardiography were performed on all monkeys
in 48 h after the last blood collection. Cardiac magnetic
resonance (CMR) were performed sequentially on some
of the monkeys. One monkey with moderate diastolic
dysfunction, together with one ND monkey was sacri-
ficed for histopathological and protein study. Some of
the pathology was detailed by use of transmission
electron microscope for observing microstructure and
ultrastructure. Immunohistochemistry staining were
performed for the protein studies.
Laboratory measurements
FPG, 2hPPG, HbA1c and lipid parameters were mea-
sured as we previously performed [23, 26]. Body mass
index (BMI) was calculated using body weight divided
by the square of CRL. Blood pressures were measured
by an intelligent non-invasive blood pressure monitor
while the monkeys were seated upon a monkey chair.
Image examination
Echocardiography: All monkeys were fasted overnight
prior to echocardiography examination. Monkeys were
sedated by ketamine hydrochloride (Bioniche Teoranta)
at a dosage of 10 mg/kg i.m. and the coat of monkey
was bilaterally shaved from the cervical part to the navel,
and rinsed copiously with water in order that acoustic
coupling was obtained using ultrasound gel. Transtho-
racic echocardiography was performed by using a com-
mercially available ultrasound system (Mindray M7vet)
with the same investigator taking the measurements
with the monkeys placed in a dorsal decubitus position
while in a stable sedation state. All measurements were
performed around the midday to avoid the influence of
circadian rhythm on the left ventricular diastolic func-
tion [27]. All echographic acquisitions were obtained
according to the recommendations of the American
Society of Echocardiography and digitally stored from at
least three consecutive heartbeats for offline analysis.
Pulsed-wave Doppler measurements: Blood flow vel-
ocity was recorded at the mitral diastolic inflow at the
level of the mitral leaflet tips from the apical 4-chamber
view. The following velocities were observed and
recorded according to the current standards of the prac-
tice of echocardiography: E wave, A wave and E/A ratio.
Early filling deceleration time (EDT) and isovolumic
relaxation time (IVRT) were measured and averaged
from 3 consecutive beats. Pulmonary venous flow (PVF)
was recorded from the same acoustic window, placing a
sampling volume 1 cm into the right upper pulmonary
vein. Peak systolic (S), diastolic (D), and atrial reversal
(AR) velocities were measured and averaged from 3 con-
secutive beats.
Conventional M-mode Doppler ultrasound: Real-time
two-dimensional targeted M-mode echocardiograms of
the LV minor axis was taken at the papillary muscle level
to measure the EF and FS. EF = (EDV-ESV)/EDV. In this
study, the values of EDV and ESV were measured by
using the Teichholz-corrected formula in standard soft-
ware included in the ultrasound equipment. EF and FS
were calculated automatically by the system when rela-
tive cardiac borders were set.
Tissue Doppler imaging: to perform this, the ultra-
sound equipment was switched into tissue Doppler
imaging mode, sample volume was located at the septal
side of the mitral annulus from the apical 4-chamber
view. Early (e’) and late (a’) diastolic mitral annulus
velocities and the ratio of early to late peak velocities
(e’/a’) were obtained.
Table 1 Gravimetry and metabolic profile of monkeys enrolled
for the study showing measurements in the acclimation period
Groups
ND T2DM
(n = 10) (n = 15)
Age (year) 12-16 12-16
BW (kg) 9.2 ± 1.9 11.3 ± 1.2
BMI 28.8 ± 2.8 38.0 ± 2.8*
Diabetes Duration (year) 0 1-4
FPG (mg/dL) day 14 82.6 ± 10.3 119.8 ± 12.9*
day 28 78.6 ± 9.8 113.9 ± 8.6*
2hPPG (mg/dL) 98.1 ± 16.4 137.8 ± 24.5*
HbA1c (%) 4.2 ± 0.4 5.1 ± 0.2*
TC (mg/dL) 131.6 ± 27.1 140.0 ± 17.6
TG (mg/dL) 44.4 ± 22.9 51.0 ± 30.9
LDL-c (mg/dL) 46.4 ± 11.6 53.7 ± 13.5
HDL-c (mg/dL) 61.4 ± 10.8 62.1 ± 11.6
SBP (mmHg) 129 ± 6 154 ± 7*
DBP (mmHg) 114 ± 7 109 ± 19
*p < 0.05, compared with ND group
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Cardiovascular magnetic resonance
In one week after echocardiography examination, CMR
imaging was performed with a 3.0-T whole-body MR
system (MAGNETOM Trio, Siemens Medical Solutions,
Erlangen, Germany) on four ND monkeys and only five
DD monkeys (anesthesia failure happened to one mon-
key with moderate DD). Intravenous propofol were used
for anesthesia induction, and inhalation isoflurane were
used for anesthesia maintenance. Data were acquired
during end-inspiratory breath holding. After scout im-
ages, TrueFISP cine sequence (TE/TR = 11/500 ms; field
of view (FOV) = 20 cm x 20 cm, NEX = 2; matrix = 256 x
256; flip angle, 50°; slice thickness = 2 mm; slice gap =
2 mm) with retrospective ECG-gating was used to
acquire dynamic cine loops of the LV for function ana-
lysis. The LV was imaged in its entirety from the base to
the apex in 9–12 short-axis cine images without inter-
slice gaps or overlaps.
Cine function analysis was performed off-line with
commercial software (Argus, Siemens Medical Solutions).
At the same mid-ventricular level, endocardial and
epicardial boundaries were traced semi-automatically
during the end-diastolic and end-systolic phases in order
to obtain the dimensional parameters: LVIDd, LVIDs,
SWTd, SWTs, AWTd, AWTs, PWTd, and PWTs. Left
ventricular cine images were analyzed by an experi-
enced radiologist who was blinded to the echocardio-
graphic results.
Light scope and transmission electron microscopy
(TEM) observation
Extracted heart, liver, kidney and pancreas of a DD mon-
key were processed for H & E staining. The ultrastruc-
ture of myocardial mitochondria were observed by
transmission electron microscope (TEM) as we previ-
ously did [28]. Fresh tissues (cardiac muscle) were cut
into 1 mm cubes, which were fixed in 3 % glutaralde-
hyde for 2 h, and then fixed in 1 % osmium tetroxide,
with stepwise dehydration in graded acetone, then after
being infiltrated and embedded, tissue was polymerized
in EPON 812. The semi-thin sections were optically
positioned and further sectioned with ultramicrotome
into 50–60 nm pieces, which were collected on copper
grids, double-stained with uranyl acetate and lead
citrate, and then observed under Hitachi H-600IV trans-
mission electron microscope and photographed.
Immunohistochemistry assessment for protein study
Five-micron serial paraffin sections of LV were used
to stain for AGEs, caspase-3 and phosphorylated
cMyBP-C. Sections were dewaxed in xylene, rehy-
drated through a graded series of ethanol, washed in
distilled water and phosphate-buffered saline (PBS),
and then blocked for endogenous peroxidase by
incubation with 3 % H2O2 in methanol for 15 min.
The sections were subjected to antigen retrieval pro-
cedure by microwaving in 0.01 M pH 6.0 sodium
citrate buffer. Additional washing in PBS was per-
formed before the next 30 min of incubation at 37 °C
in 10 % normal goat serum. The sections were incu-
bated overnight at 4 °C with diluted (1:100) primary
antibodies. The antibodies used were polyclonal goat
anti-rabbit AGEs antibodies, goat anti-rabbit caspase-
3 antibody and goat anti-rabbit phosphorylated
cMyBP-C antibody (Boster, China). For negative con-
trols, the sections received PBS in place of the primary
antibody. After washing in PBS, the sections were
exposed to a 1 % biotinylated secondary antibody goat
and anti-rabbit IgG (Boster, China) for 1 h at 37 °C. The
sections were then incubated with the HRP-streptavidin
(Boster, China) for 30 min at 37 °C. To visualize the
immunoreaction, the sections were immersed in blue
diaminobenzidine hydrochloride (DAB). The reaction
was monitored microscopically and stopped by the
immersion into distilled water as soon as a brown color
staining was clearly visualized.
Statistical analysis
Statistical analysis was performed using SPSS 19.0 soft-
ware. The data is presented as the mean ± SD unless
otherwise specified. Comparison among the two groups
of subjects for various parameters was carried out by
one-way analysis of variance. When normality and/or
equal variance testing conditions were not met, the
Kruskal-Wallis rank test and/or the Dunn's test for mul-
tiple comparisons were used, respectively. A p value less
than 0.05 was considered statistically significant.
Results
Gravimetry and metabolic profile
Hyperglycemia and elevated HbA1c percentage were
confirmed in all spontaneous T2DM monkeys enrolled
(Table 1). In terms of both of the FPG determinations,
T2DM group showed significantly higher FPG level
compared with the ND group. All T2DM monkeys
enrolled not only met our criteria for T2DM, but also
showed relatively stable FPG in the acclimation period.
2hPPG and HbA1c percentage in the T2DM group
were also significantly higher than those in ND group
(137.8 ± 24.5 vs 98.1 ± 16.4 mg/dL for 2hPPG, p < 0.05;
5.1 ± 0.2 vs 4.2 ± 0.4, %, for HbA1c, p < 0.05). Obesity
was observed in all T2DM monkeys, whose BMI
average body weight was larger than that of ND group
(38.0 ± 2.8 vs 28.8 ± 2.8, kg/m2, p < 0.05), while there
was no significance in body weight (11.3 ± 1.2 vs 9.2 ±
1.9, kg). There were no significant differences between
groups in their lipid profiles. Average systolic blood
pressure of the diabetic monkeys was found to be
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higher than that of the ND monkeys (154 ± 7.0 vs 129 ±
5.6, mmHg, p < 0.05).
Echocardiography findings
The monkeys tolerated the anesthesia and procedure
without difficulty. There were no post study deaths.
Echocardiograms with high definition were acquired
from all monkeys, representative echo images were
shown in Fig. 1. Six out of 15 T2DM monkeys were
found having manifestations that are similar to those of
human patients with diastolic dysfunction. These six
monkeys all showed low e’ velocity and a decreased e’/a’
ratio. Among these six monkeys, three showed decreased
E/A ratio (below 0.9), which was similar to the echo-
graphic characteristics of mild diastolic dysfunction in
human patients. While another three monkeys showed
increased E/A ratio (above 1.3) accompanying abnormal-
ities of the TDI parameters described above, which were
similar to the manifestations of moderate diastolic dys-
function in human patients. Since there are no criteria
for diastolic function grading in monkeys, we attempt
here to classify all monkeys enrolled into 4 groups: ND,
T2DM with preserved DD, mild DD (considered as
impaired relaxation) and moderate DD (pseudonormal
pattern), for the following analyzes.
In ND (n = 10) and T2DM with preserved diastolic
function (n = 9) subjects averaged E/A ratio for both
groups were slightly greater than 1 (1.1 ± 0.2 and 1.2 ±
0.2, see Table 2, Fig. 2), while E/A ratio significantly
decreased in mild DD group (0.8 ± 0.1, n = 3) but in-
creased in moderate DD group (1.5 ± 0.2, n = 3). Mitral
annulus velocity e’ were 8.7 ± 0.6 cm/s for the ND group
and 9.3 ± 0.9 cm/s for the T2DM with preserved dia-
stolic function group, while e’ velocity decreased in DD
subjects: 5.7 ± 1.7 cm/s for the mild DD group and 7.7 ±
1.6 cm/s for the moderate DD group. Significance was
only found between the T2DM with the preserved dia-
stolic function group and the mild DD group (p < 0.05).
e’/a’ ratio was found to be 1.2 ± 0.3 for the ND group
and 1.4 ± 0.3 for the T2DM with preserved diastolic
function group, however this parameter decreased
below 1 in the DD subjects: 0.7 ± 0.1 for the mild DD
group (p < 0.01 compared with the T2DM group with
preserved diastolic function) and 0.8 ± 0.1 for the
moderate DD group (p < 0.01 compared with the
T2DM with preserved diastolic function group).
The mild DD group had the longest average EDT (See
Table 2). Significant difference was found between the
mild DD group and the T2DM with preserved LV func-
tion group (92 ± 20 vs 66 ± 18, ms, p < 0.05). However,
the difference between mild DD group and the moderate
DD group was not significant. As for the IVRT, no
significances were found among any of the groups.
As for pulmonary venous flow pattern, monkeys in the
ND group and T2DM with preserved LV function group
showed similar levels of S, D and AR (See Table 2 and
Fig. 3). In normal PVF patterns, values of S/D were
around 1. In monkeys with mild DD, we have the
highest peak S (61.4 ± 9.0 cm/s) and lowest D (37.1 ±
2.0 cm/s), resulting in the highest S/D ratio in this
group. However, peak S decreased but D increased in
the group with pseudonormal pattern, which lead to
S/D < 1. As for PV AR velocity, though the highest AR
waves were seen in the mild DD group, nonetheless,
Fig. 1 Representative images of echo patterns of mitral inflow, pulmonary venous flow and mitral annulus velocity from normal to moderate
diastolic dysfunction in rhesus monkeys
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the differences among groups were not statistically
significant.
M-mode Doppler ultrasound was used for the meas-
urement of left ventricular contractile capacity. Left
ventricular systolic function related parameters EF and
FS share similar characteristics (Fig. 4). They showed a
tendency to decrease in accordance with the following
order: ND, T2DM with preserved diastolic function,
mild DD and moderate DD. Though there were sig-
nificant differences between the moderate DD group
and ND group (EF: 63.1 ± 7.0 vs 76.8 ± 4.9, %, p < 0.05;
FS: 28.6 ± 4.5 vs 43.0 ± 4.0, %, p < 0.001) for these two
parameters, whether they were still within normal
physical limits still needs to be further studied.
Cardiac magnetic resonance findings
Left ventricular cine images at the mid-ventricular
level were obtained from 5 DD monkeys and 4 ND
monkeys who have been through the echocardio-
graphic examination (Fig. 5). LV internal diameter
(LVID), anterior, posterior and septum wall thickness
(AWT, PWT, SWT) were measured at both end dia-
stole (d) and end systole (s). In DD group, LVID mea-
sured at the end of systole were significantly longer
Table 2 Echocardiographic measurements in 10 ND monkeys
and 15 spontaneous T2DM monkeys








(n = 3) (n = 3)
(n = 9)
transmitral flow
E/A 1.1 ± 0.2 1.2 ± 0.2 0.8 ± 0.1* 1.5 ± 0.2*#
EDT (ms) 70 ± 12 66 ± 18 92 ± 20* 75 ± 10
IVRT (ms) 48 ± 7 51 ± 10 55 ± 16 49 ± 19
pulmonary
venous flow
S(cm/s) 46.8 ± 6.1 48.5 ± 11.0 61.4 ± 9.0* 38.2 ± 2.7#
D(cm/s) 43.8 ± 11.0 45.9 ± 10.8 37.1 ± 2.0 56.9 ± 4.5*#
AR(cm/s) 43.7 ± 11.2 42.1 ± 7.9 54.7 ± 13.1 44.4 ± 2.0
myocardial
velocities
e’(cm/s) 8.7 ± 0.6 9.3 ± 0.9 5.7 ± 1.7* 7.0 ± 0.4
e’/a’ 1.2 ± 0.3 1.4 ± 0.3 0.7 ± 0.1* 0.8 ± 0.1*
LA diameters
LAAD (mm) 16.8 ± 1.0 15.1 ± 1.1 15.1 ± 2.1 15.7 ± 1.8
LATD (mm) 18.4 ± 0.7 17.8 ± 3.4 16.2 ± 2.0 16.8 ± 3.8
LAVD (mm) 21.6 ± 2.1 21.0 ± 2.2 19.3 ± 3.0 22.0 ± 5.9
*p < 0.05 compared with the T2DM with preserved diastolic function group
#p < 0.05 compared with the impaired relaxation group
Fig. 2 Diastolic function related parameters measured by
echocardiography. *p < 0.05, **p < 0.01
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than that of ND (21.8 ± 2.9 vs 17.5 ± 0.1, mm, p < 0.05).
As for LV wall thickness parameters (AWTd, AWTs,
PWTs), they all showed a tendency to be thinner in
the DD group than those in the ND group but still
without statistical significance.
Myocardial microstructure and ultrastructure findings
Pathologic analyses were used to assess the myocardial
microstructure of a monkey with moderate LV dia-
stolic dysfunction. H&E staining revealed myocardium
swelling with granular degeneration and myocardial
atrophy accompanying interstitial expansion (Fig. 6a).
At the same time, lesions were found in other major
organs: liver, kidney and pancreas (Fig. 6b, c and d).
Firstly, cellular atrophy, hepatic sinusoid expansion,
multifocal proliferation of the connective tissue and
hepatic cords vanishment were found in the section of
liver tissue. Secondly, shrinkage of the glomerulus,
kidney tubules granular degeneration and sectional
tubular epithelial detachment were observed in the
Fig. 3 Pulmonary venous flow parameters measured by
echocardiography. *p < 0.05, **p < 0.01
Fig. 4 Systolic function related parameters measured by
echocardiography. *p < 0.05
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section of kidney tissue. Thirdly, cellular swelling,
decreasing cell numbers and cell shrinkage were ob-
served in the section of pancreas tissue. Transmission
electron microscopy was used to observe the mito-
chondrial ultrastructure of the hearts of a ND monkey
and a monkey with moderate diastolic dysfunction
(Fig. 7a and b). In the myocardial mitochondria of a
ND monkey, mitochondria were regularly shaped and
arranged between myofilaments with the cristae being
clear and undamaged. However mitochondrial swell-
ing and vacuolation, atrophy and rupture of myocar-
dial fibers along with nuclear chromatin migration
towards the cell’s edge are observed in the DD monkey
images.
Cardiac protein study
Immunohistochemical stains were used to assess the ex-
pression of different kinds of protein metabolized in the
heart. AGEs, caspase-3 and phosphorylated cMyBP-C
were stained by blue diaminobenzidine hydrochloride
(DAB). Increased expression of AGEs, caspase-3 and
decreased cMyBP-C phosphorylation in myocardium
were observed by light-microscopic examination (Fig. 8),
which were reflected by positive staining of these pro-
teins throughout the field of microscope. However, there
were no observable abnormal staining patterns as these
in the sections of the ND monkey heart.
Discussion
Echocardiography and CMR have been used for invasive
cardiac phenotype assessment in diabetic animal models
[15, 17, 18, 29] and humans [7, 8, 30–35]. Since there is
no single diagnostic method for the identification of
diastolic dysfunction, these tools can be complementary.
Echocardiography is an invasive and inexpensive tool
that allows sonographers to evaluate changes in heart
structure/function that are echogenic. This technique
has been already used to assess the cardiac structure and
function in non-human primates [36–39], all for estab-
lishing standardized echocardiographic reference values.
Mitral valve blood inflow measured by pulsed-wave
Doppler and tissue Doppler imaging were combined to
assess diastolic function in the hearts of monkeys.
Normal pattern for diastolic function under pulsed-wave
Doppler were defined as E/A > 1 in human. However,
this value may also be observed at early stages of
ischemia and hypertrophy. Doppler pattern of impaired
LV relaxation, characterized by reduced early and
increased late diastolic flow, is an early sign of DD (mild
diastolic dysfunction) which shows E/A < 1 [40]. More
advanced grades, manifested by predominant early
diastolic filling and rapid velocity deceleration, known as
restrictive filling patterns, cause an increase in filling
pressure, lead to an increase in the E-wave, and result in
a E/A ratio > 2 [41]. The hinge point of these grades is
the intermediary values, the pseudonormal pattern or
moderate DD group, has an E/A > 1 which results from
an increase in the left atrial pressure [41] in the presence
of a defective relaxation. The impaired LV relaxation
leads to an increase in filling pressures in order to main-
tain normal cardiac output as a complement of the vari-
ables of mitral valve inflow velocity. A combination of
Fig. 5 Cardiac cine-MR results measured from 5 DD monkeys and 4
ND monkeys. a End-diastolic (left) and end-systolic (right) cine-MR
images in a mid-ventricular slice from a DD (top) and an ND (bottom)
monkey. b Left ventricular internal dimension measured at both end
diastole and end systole. c Left ventricular wall thickness measured at
both end diastole and end systole
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mitral annulus velocity with peak e’ velocity < 8.5 cm/s
and e’/a’ ratio < 1 was used to indicate relaxation abnor-
mality, this mitral annulus velocity pattern could identify
the underlying relaxation abnormality with a sensitivity
of 88 % and specificity of 67 % [31]. Moreover, mitral
annulus motion is less load dependent than conventional
mitral inflow variables. This technique appears to be
useful for evaluating diastolic function, especially in the
detecting of a pseudonormal pattern. In this study, DD
diagnosing and grading were referred to as a combin-
ation of parameters measured from pulsed-wave Doppler
and TDI. Monkeys in ND group and T2DM with pre-
served diastolic function group showed that E/A > 1, e’
velocity < 8 cm/s, e’/a’ < 1 and E/e’ > 8. Subjects with
E/A < 0.9 (impaired relaxation) and E/A > 1.3 (pseudo-
normal) were considered as mild DD and moderate DD,
which were supported by TDI results such as decreased
e’ velocity and e’/a’ < 1. The E/A ratio measured from
T2DM monkeys in our trials was found to show a
U-shaped prognostic behavior, which were similar to
T2DM patients [7, 42].
Impairment of LV relaxation results in prolongation of
the IVRT and EDT. In contrast, increasing filling
pressure shortens IVRT and reduces EDT [43]. In this
study, the mild DD group had the longest average EDT.
Significant difference was found between the mild DD
group and the T2DM with preserved diastolic function
group. Though the difference of EDT between mild DD
and the moderate DD groups were not significant, there
was a tendency to register a decrease in the moderate
DD group. As for the IVRT, no significances were found
among groups. Heart rates (HR) of monkeys are usually
twice or three times faster than that of the human being.
During our echo study, heart rates ranged from 110 to
175 bpm when monkeys were sedated by ketamine. The
wide variability of HR can influence the IVRT and EDT
in evaluating the LV diastolic function.
Pulmonary venous flow pattern has also been used to
distinguish normal from pseudonormal transmitral
Doppler filling. Impairment of LV relaxation results in
increased systolic (S) pulmonary venous flow, in contrast
increasing filling pressure reduces PV systolic flow [43].
It has been reported that PVF indexes also change in a
typical U-shaped pattern during the progression from
normal to severe DD. In this study, the highest peak
S and S/D ratio were seen in the mild DD group, whereas
S was reduced in the moderate DD group and resulted in
the reversal of S/D ratio (S/D < 1). As for AR velocity,
differences between groups were unremarkable, which
may be caused by the relative difficulty in obtaining
Fig. 6 Myocardial microstructure and ultrastructure pictures observed by light scope and transmission electron microscope. a, b, c and d
Myocardium, liver, kidney and pancreas pathological image of a DD monkey, respectively
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accurate tracings by the transthoracic approach. Assisted
by the TDI indexes, the PVF patterns seen provided more
evidence of DD in these monkeys.
Decreased EF and FS were only seen in moderate DD
subjects. It is still under debate as to which left ventricu-
lar function is impaired earlier in the evolution of
diabetic cardiomyopathy. More studies stated that
diastolic function is more commonly impaired than sys-
tolic and that diastolic dysfunction might be the initial
abnormality in patients with the onset of diabetes [5, 7,
9, 42, 44, 45]. However, other researchers have recently
shown that systolic strain alterations may exist despite
normal diastolic function, which indicates systolic strain
abnormality might be proposed as the first indicator of
diabetic cardiomyopathy [46]. According to the results
of the groupings in this study, significances of EF and FS
were only found between the moderate DD group and
ND group, indicating that diastolic dysfunction may be
the earliest functional alteration in the course of diabetic
cardiomyopathy, which lead to contractile abnormality
with the progression of DD in spontaneous T2DM
rhesus monkeys.
MRI provides accurate, reproducible, noninvasive
representations of cardiac structure and function and
measurements of regional myocardial wall thickening
[47]. This non-invasive imaging tool has been proved to
be powerful in evaluating the cardiac morphology of the
diabetic rodent models [15, 17] and patients [35].
However, in vivo cine MRI studies on T2DM monkey
models are very limited. In the present study, it was
observed that T2DM rhesus monkeys with diastolic
dysfunction showed significantly dilated LV internal
diameter at end systole compared with ND monkeys.
Though statistical differences were not seen, average LV
internal diameter at end diastole were 12 % higher in
DD subjects when compared with the ND group. These
cardiac structural changes reflex the adaptive mechan-
ism of reduced relaxation and contractility. As for left
ventricular wall and septum thickness, no significant
changes were seen between DD subjects and ND mon-
keys. Similarly, LV dilatation were accompanied by no
significant changes in LV wall thickness as observed in
diabetes rodents [48–50]. In this study, alterations of
systolic function indicators were observed with the
progression of DD by echocardiography, which included
reductions in EF and FS. Increases in LV inner dimen-
sions were also indicators of reduced contractile ability.
Though significant changes were not found in LV wall
and septal thickness, the average PWTd, PWTs and
SWTs of the DD monkeys were 18.3 %, 11.9 % and
17.4 % all lower values than found in the ND ones. In a
study using STZ treated rats [48, 50], it reported there is
a gradual decrease in PWT after 8 weeks of diabetes
while continuing after 12 weeks of recorded measure-
ments. A relatively small sample number in this study
may be a limitation in observing the differences
between groups. Moreover, additional longitudinal
studies are needed to trace the alteration with the
progression of diabetes.
Histological abnormalities of myocardium were re-
ported both in diabetic rodent models and human
patients [51–53]. Characteristics of the pathological
changes of the myocardium in the T2DM accompany-
ing DD monkeys were consistent with the previous
DCM studies. Meanwhile, lesions found in the liver,
kidney and pancreas indicates that other diabetes com-
plications also exist in these monkeys. Mitochondrial
Fig. 7 Myocardium ultrastructure TEM image of an ND monkey and
a DD monkey. a ND monkey; b DD monkey
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ultrastructure damage were also observed by TEM.
Many laboratories have generated data suggesting that
diabetic damage is a consequence of elevated produc-
tion of reactive oxygen species (ROS) found at the
mitochondrial respiratory chain during hyperglycemia
[54, 55]. More and more laboratory findings support
the hypothesis that mitochondrial ROS mediated the
diabetes induced cardiac defects. Manifestations of
mitochondria in our DCM rhesus monkeys were similar
to those in previous rodent studies.
Assisted by immunohistochemistry stain, positive
products were observed to be abnormally expressed in
the DCM monkey myocardium compared with the ND
monkey. The formation of AGEs on extracellular matrix
components leads to accelerated increases in collagen
cross linking that contributes to the myocardial stiffness
in diabetes [10]. Apoptotic cell death occurs in
the diabetic myocardium through the mitochondrial
cytochrome c-mediated caspase-3 activation pathway,
which plays a critical role in cardiac pathogenesis related
to hyperglycemia [11]. Basal levels of cMyBP-C phos-
phorylation may be necessary for maintaining thick-
filament orientation, dynamic regulation and contractile
mechanics [12]. However, cMyBP-C phosphorylation
was significantly decreased during the development of
heart failure or pathologic hypertrophy. Phosphorylated
cMyBP-C were lightly stained in the myocardium of the
DCM monkey, which is indicative of contractile abnor-
mality. Thus, myocardial impairments were observed at
molecular level in abnormal organ functioning.
The spontaneously diabetic monkeys are of great
importance in both biomedical investigation and for
pharmaceutical studies. Literatures and our previous
work demonstrated that the clinical manifestations of
T2DM monkeys were highly similar to those of human
beings. Results show that some if not most of our
middle-aged rhesus monkeys were confirmed to have
obesity, β-cell impairment, insulin level decline and per-
sistent hyperglycemia verifying the development of spon-
taneous T2DM. The FPG of healthy monkeys in our
monkey model is only approximately 10 %-15 % lower
than that of humans. As for DD in monkeys diagnosed
by echocardiography, relative parameters exhibit human-
like echo patterns with diastolic dysfunction progression,
which has not been reported in rodent models. As for
other features like MRI parameters, cardiac structure
and biomarkers in cardiomyopathy, the monkeys share
the same features as reported in human and rodents.
Moreover, the development of spontaneous diabetes and
its complications is a multifactorial slow progression. Of
note, monkeys have a long enough life span that allows
both disease progression and thorough longitudinal
studies, which may shed light on the origins, pathways
and pathogenesis of these pathologic changes. Mean-
while, these monkeys live in a highly controlled and
stable environment with their metabolic history well
documented. Thus long-term relationships between
cardiovascular pathology changes and diabetic status can
now be studied without the confounding lifestyle factors
encountered in humans.
Limitations of the study
The present study primarily demonstrated diastolic
dysfunction and related myocardial impairments in
spontaneous T2DM rhesus monkeys. Nevertheless, there
are several limitations need to be addressed. Firstly, the
echocardiographic parameters we examined in this study
were not so sufficient as to allow us to draw a full pic-
ture of the dimension and function of the ventricle. It
has been reported that EDV, ESV, and Vp obtained by
Fig. 8 Immunohistochemistry stain results of AGEs, caspase-3 and cMyBP-C of an ND monkey and a DD monkey respectively
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color M-mode Doppler also change with cardiac dys-
function in a diabetic heart. Secondly, CMR can provide
more information about cardiomyopathy by using late
gadolinium enhancement (LGE), MR tagging and T1
mapping, which we unfortunately failed to obtain in the
present study. We are planning to further investigate
DCM in rhesus monkeys by CMR in the near future. In
consideration of the maintenance of the model, we only
sacrificed 2 monkeys for invasive measurements. Luckily,
certain myocardial impairments were observed on both
microstructure and ultrastructure levels. However, quan-
tified measurements of these biomarkers need to be
done on a larger scale for these animals to determine
reliability. We are also preparing non-invasive assess-
ments for a better understanding of the mechanisms of
these biomarkers and more, hoping to provide evidence
for the hypotheses proposed regarding the pathogenesis
of DCM.
Conclusions
The present study primarily demonstrated cardiomyop-
athy in spontaneous T2DM rhesus monkeys. Left
ventricular diastolic dysfunction was diagnosed in six
out of 15 T2DM monkeys, accompanied with structural
abnormalities such as significantly increased LVID at
end systole. Systolic related parameters, EF and FS, de-
creased with DD progression, however significance was
found only between the moderate DD group and the
ND group. Myocardial microstructure and ultrastructure
damages were observed in a DD monkey. Meanwhile,
the expression of DCM related proteins altered in a DD
monkey. Characteristics of cardiomyopathy in spontan-
eous T2DM monkeys with DD are similar to those in
DCM human patients. We will not only conduct more
studies in these subjects for further investigations, but
we will also screen for more diseased animals in the
future to create a more effective drug testing platform.
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